The second branch
of the combination therapy, the low - dose metronomic chemotherapy, was similarly found to exert its therapeutic effect through a novel, hitherto
unrecognized mechanism: The metronomic chemotherapy turned out to not primarily target the tumor
cells, but to act on the recruitment
of yet another tumor - promoting
cell population from the bone marrow.